0001127602-14-020097.txt : 20140624
0001127602-14-020097.hdr.sgml : 20140624
20140605204053
ACCESSION NUMBER: 0001127602-14-020097
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140605
FILED AS OF DATE: 20140605
DATE AS OF CHANGE: 20140605
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp
CENTRAL INDEX KEY: 0001082554
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 521984749
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
BUSINESS PHONE: 3016089292
MAIL ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
FORMER COMPANY:
FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP
DATE OF NAME CHANGE: 19990324
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MAHON PAUL A
CENTRAL INDEX KEY: 0001231589
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26301
FILM NUMBER: 14894940
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2014-06-05
0001082554
UNITED THERAPEUTICS Corp
UTHR
0001231589
MAHON PAUL A
C/O UNITED THERAPEUTICS CORPORATION
1040 SPRING STREET
SILVER SPRING
MD
20910
1
EVP & General Counsel
Common Stock
2014-06-05
4
M
0
6000
30.75
A
40832
D
Common Stock
2014-06-05
4
S
0
3745
96.2138
D
37087
D
Common Stock
2014-06-05
4
S
0
2255
96.9678
D
34832
D
Stock Options
30.75
2014-06-05
4
M
0
6000
0
D
2015-12-15
Common Stock
6000
2000
D
This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
Exercise price and number of shares/awards has been adjusted to reflect the issuer's two-for-one stock split on September 22, 2009.
This transaction was executed in multiple trades at prices ranging from $95.79 to $96.78. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $96.80 to $97.18. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
These stock options became exercisable on 12/26/2009.
/s/ John S. Hess, Jr. under Power of Attorney
2014-06-05